This blog entry is for everyone and anyone who has not been able to keep up with the huge initiative at the National Cancer Institute. It just might have the answers to a specific Cancer question. By attending an NCI conference in Washington DC I have a much clearer picture of the opportunities and challenges …
caBIG/NCI: Enabling the Next Wave of Cancer Research and Care. Read More »
I have written quite a bit on the subject of Molecular Profiling only to find out that the glossary of terms around this subject are many and varied. Having now spent several hours researching this subject at the National Cancer Institute perhaps their label of Molecular Diagnostics is most common. To that end take a …
Fact – The National Cancer Institue 2007 Report on Trends in Cancer made no mention of Molecular Profiling, in spite of its most recent significant contributions to the field of diagnosis and treatment therapies. I would welcome an explanation from NCI or any practicing professional in cancer research.
New Study of Targeted Therapies for Breast Cancer Establishes Model for Global Clinical Trials Two targeted medications designed to treat an aggressive form of breast cancer are being tested in a new study involving 8,000 participants in 50 countries across six continents — a clinical trial that investigators hope will provide a new model for …
Side-Out is a proud member of the
© The Side-Out Foundation is a 501(c)(3) non-profit organization. EIN 20-2510044
Dig Pink® is a registered trademark of the Side-Out Foundation
